The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Solid Lipid Nanoparticles: Emerging Colloidal Nano Drug Delivery Systems
Open accessAbstract
Solid lipid nanoparticles (SLNs) are nanocarriers developed as substitute colloidal drug delivery systems parallel to liposomes, lipid emulsions, polymeric nanoparticles, and so forth. Owing to their unique size dependent properties and ability to incorporate drugs, SLNs present an opportunity to build up new therapeutic prototypes for drug delivery and targeting. SLNs hold great potential for attaining the goal of targeted and controlled drug delivery, which currently draws the interest of researchers worldwide. The present review sheds light on different aspects of SLNs including fabrication and characterization techniques, formulation variables, routes of administration, surface modifications, toxicity, and biomedical applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00118-7 · Cited by 2,113
Solid lipid nanoparticles: A modern formulation approach in drug delivery system
Mukherjee, S., Ray, S., & Thakur, R. (2009) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.57282 · Cited by 1,000
Mehnert, W., & Mäder, K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.021 · Cited by 981
Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery
Das, S., & Chaudhury, A. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-010-9563-0 · Cited by 838
Solid lipid nanoparticles as a drug delivery system for peptides and proteins☆
ALMEIDA, A., & SOUTO, E. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.007 · Cited by 814
Nanostructured lipid carriers for site-specific drug delivery
Khosa, A., Reddi, S., & Saha, R. N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.055 · Cited by 619
Detergent-like actions of linear amphipathic cationic antimicrobial peptides
Bechinger, B., & Lohner, K. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.07.001 · Cited by 593
Jenning, V., Thünemann, A. F., & Gohla, S. H. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00378-1 · Cited by 593
Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles
Venkateswarlu, V., & Manjunath, K. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.01.005 · Cited by 558
Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties
Jenning, V., Schäfer-Korting, M., & Gohla, S. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00223-0 · Cited by 545
Üner, M., & Yener, G. (2007) · PubMed Central · Cited by 543
Westesen, K., Bunjes, H., & Koch, M. H. J. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00046-1 · Cited by 536
Nanoparticles synthesis using supercritical fluid technology – towards biomedical applications
Byrappa, K., Ohara, S., & Adschiri, T. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.001 · Cited by 487
Yang, S. C., Lu, L. F., Cai, Y., Zhu, J. B., Liang, B. W., & Yang, C. Z. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00007-3 · Cited by 476
Role of Nanotechnology in Cosmeceuticals: A Review of Recent Advances
Kaul, S., Gulati, N., Verma, D., Mukherjee, S., & Nagaich, U. (2018) · Journal of Pharmaceutics · doi:10.1155/2018/3420204 · Cited by 435
Ganesan, P., & Narayanasamy, D. (2017) · Sustainable Chemistry and Pharmacy · doi:10.1016/j.scp.2017.07.002 · Cited by 434
Geszke-Moritz, M., & Moritz, M. (2016) · Materials Science and Engineering: C · doi:10.1016/j.msec.2016.05.119 · Cited by 392
Nanosystems in Edible Coatings: A Novel Strategy for Food Preservation
Zambrano-Zaragoza, M., González-Reza, R., Mendoza-Muñoz, N., Miranda-Linares, V., Bernal-Couoh, T., Mendoza-Elvira, S., & Quintanar-Guerrero, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030705 · Cited by 313
Solid lipid nanoparticles as drug delivery systems
Manjunath, K., Reddy, J. S., & Venkateswarlu, V. (2005) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2005.27.2.876286 · Cited by 306
Sun, J., Bi, C., Chan, H. M., Sun, S., Zhang, Q., & Zheng, Y. (2013) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2013.06.032 · Cited by 277
Nanotoxicity: A Key Obstacle to Clinical Translation of siRNA-Based Nanomedicine
Xue, H. Y., Liu, S., & Wong, H. L. (2014) · Nanomedicine · doi:10.2217/nnm.13.204 · Cited by 250
Solid Lipid Nanoparticles: A Review
., S. C. V., ., S. V., & ., U. U. (2011) · Journal of Current Pharma Research · doi:10.33786/jcpr.2011.v01i04.009 · Cited by 249
Lipid Nanoparticles: Production, Characterization and Stability
Shah, R., Eldridge, D., Palombo, E., & Harding, I. (2015) · SpringerBriefs in Pharmaceutical Science & Drug Development · doi:10.1007/978-3-319-10711-0 · Cited by 219
Solid lipid based nanocarriers: An overview / Nanonosači na bazi čvrstih lipida: Pregled
Pardeshi, C., Rajput, P., Belgamwar, V., Tekade, A., Patil, G., Chaudhary, K., & Sonje, A. (2012) · Acta Pharmaceutica · doi:10.2478/v10007-012-0040-z · Cited by 214
Lipid Nanoparticles: Effect on Bioavailability and Pharmacokinetic Changes
Souto, E. B., & Müller, R. H. (2010) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-00477-3_4 · Cited by 210
Westesen, K., Siekmann, B., & Koch, M. H. J. (1993) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(93)90177-h · Cited by 206
Baek, J.-S., & Cho, C.-W. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.04.013 · Cited by 204
Solid Lipid Nanoparticles (SLN): Method, Characterization and Applications
Garud, A., Singh, D., & Garud, N. (2012) · International Current Pharmaceutical Journal · doi:10.3329/icpj.v1i11.12065 · Cited by 202
Kushwaha, A. K., Vuddanda, P. R., Karunanidhi, P., Singh, S. K., & Singh, S. (2013) · BioMed Research International · doi:10.1155/2013/584549 · Cited by 201
Saupe, A., Gordon, K. C., & Rades, T. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.01.022 · Cited by 199
Biocompatibility of chemically cross-linked gelatin hydrogels for ophthalmic use
Lai, J.-Y. (2010) · Journal of Materials Science: Materials in Medicine · doi:10.1007/s10856-010-4035-3 · Cited by 179
Adapalene loaded solid lipid nanoparticles gel: An effective approach for acne treatment
Jain, A. K., Jain, A., Garg, N. K., Agarwal, A., Jain, A., Jain, S. A., Tyagi, R. K., Jain, R. K., Agrawal, H., & Agrawal, G. P. (2014) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2014.05.041 · Cited by 176
Olbrich, C., Gessner, A., Kayser, O., & Müller, R. H. (2002) · Journal of Drug Targeting · doi:10.1080/1061186021000001832 · Cited by 175
Cyclosporine A loaded SLNs: Evaluation of cellular uptake and corneal cytotoxicity
Gokce, E. H., Sandri, G., Bonferoni, M. C., Rossi, S., Ferrari, F., Güneri, T., & Caramella, C. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.028 · Cited by 159
Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin
Jain, A., Kesharwani, P., Garg, N. K., Jain, A., Jain, S. A., Jain, A., Nirbhavane, P., Ghanghoria, R., Tyagi, R. K., & Katare, O. P. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.06.027 · Cited by 156
Adib, Z. M., Ghanbarzadeh, S., Kouhsoltani, M., Khosroushahi, A. Y., & Hamishehkar, H. (2016) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2016.06 · Cited by 153
Recent Advances in the Development of Antimicrobial Nanoparticles for Combating Resistant Pathogens
Lakshminarayanan, R., Ye, E., Young, D. J., Li, Z., & Loh, X. J. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701400 · Cited by 149
Preservation of nanostructured lipid carriers (NLC)
Obeidat, W. M., Schwabe, K., Müller, R. H., & Keck, C. M. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.05.001 · Cited by 133
Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin
Cavalli, R., Bargoni, A., Podio, V., Muntoni, E., Zara, G. P., & Gasco, M. R. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10368 · Cited by 133
Ebrahimi, H. A., Javadzadeh, Y., Hamidi, M., & Barzegar-Jalali, M. (2015) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/s40199-015-0128-3 · Cited by 130
Aldayel, A. M., O’Mary, H. L., Valdes, S. A., Li, X., Thakkar, S. G., Mustafa, B. E., & Cui, Z. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.035 · Cited by 129
Rawat, M. K., Jain, A., & Singh, S. K. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22435 · Cited by 123
Lu, B., Xiong, S.-B., Yang, H., et al. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.01.001 · Cited by 120
Silva, A. C., Kumar, A., Wild, W., Ferreira, D., Santos, D. F. G., & Forbes, B. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.058 · Cited by 118
Nanocosmetics and Nanomedicines
(2011) · doi:10.1007/978-3-642-19792-5 · Cited by 116
Kelidari, H., Saeedi, M., Âkbari, J., Morteza‐Semnani, K., Gill, P., Valizadeh, H., & Nokhodchi, A. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.02.046 · Cited by 112
Dolatabadi, J. E. N., Hamishehkar, H., Eskandani, M., & Valizadeh, H. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.01.055 · Cited by 107
Jain, V. K., Gupta, A., Pawar, V. K., Asthana, S., Jaiswal, A. K., Dube, A., & Chourasia, M. K. (2014) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-014-1084-y · Cited by 106
Effect of beeswax modification on the lipid matrix and solid lipid nanoparticle crystallinity
Attama, A. A., & Müller-Goymann, C. C. (2007) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2007.07.035 · Cited by 104
Lipid Nanoparticles as Drug/Gene Delivery Systems to the Retina
del Pozo‐Rodríguez, A., Delgado, D., Rodríguez‐Gascón, A., & Solinís, M. Á. (2013) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2012.0128 · Cited by 101
Cytotoxicity of submicron emulsions and solid lipid nanoparticles for dermal application
Weyenberg, W., Filev, P., den Plas, D. V., et al. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.12.045 · Cited by 101
Solid Lipid Nanoparticle: A Review
Joshi, R. K. H. (2012) · IOSR Journal of Pharmacy (IOSRPHR) · doi:10.9790/3013-26103444 · Cited by 100
Role of solid lipid nanoparticles as photoprotective agents in cosmetics
Jose, J., & NETTO, G. (2018) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.12504 · Cited by 95
Padhye, S., & Nagarsenker, M. S. (2013) · PubMed Central · Cited by 94
Dwivedi, P., Khatik, R., Khandelwal, K., Taneja, I., Kanumuri, R. S., Wahajuddin, M., Paliwal, S., Dwivedi, A. K., & Mishra, P. R. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.03.036 · Cited by 94
Singh, H., Bhandari, R., & Kaur, I. P. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.012 · Cited by 91
Wang, F., Li, L., Liu, B., et al. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.12.041 · Cited by 86
Recent therapeutic approaches for the management of tuberculosis: Challenges and opportunities
Patil, K. D., Bagade, S. B., Bonde, S., Sharma, S., & Saraogi, G. K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.115 · Cited by 85
Abbas, H., Refai, H., & Sayed, N. S. E. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.04.007 · Cited by 84
Castellani, S., Trapani, A., Spagnoletta, A., di Toma, L., Magrone, T., Gioia, S. D., Mandracchia, D., TRAPANI, G., Jirillo, E., & Conese, M. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1509-4 · Cited by 83
Scaling up feasibility of the production of solid lipid nanoparticles (SLN).
Gohla, S., & Dingler, A. (2001) · PubMed · Cited by 78
Kim, S., Stébé, M., Blin, J., & Pasc, A. (2014) · Journal of Materials Chemistry B · doi:10.1039/c4tb01133c · Cited by 72
Production of Solid Lipid Nanoparticles-Drug Loading and Release Mechanism
Parhi, R., & Suresh, P. (2010) · Journal of chemical and pharmaceutical research · Cited by 68
Chiu, H., Chen, H., Huang, W., Chiang, W., Liu, T., Shen, M., Hsu, Y., & Lin, S. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s86053 · Cited by 66
Solid lipid nanoparticles as delivery systems for Gambogenic acid
Huang, X., Chen, Y., Peng, D., Li, Q., Wang, X., Wang, D., & Chen, W. (2012) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2012.08.058 · Cited by 64
Rehman, M., Ihsan, A., Madni, A., Bajwa, S. Z., Shi, D., Webster, T. J., & Khan, W. S. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s147506 · Cited by 59
Li, J., Guo, X., Liu, Z., Okeke, C. I., Li, N., Zhao, H., Aggrey, M. O., Pan, W., & Wu, T. (2013) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2013.795582 · Cited by 58
Eskandani, M., & Nazemiyeh, H. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.04.009 · Cited by 57
Saljoughian, N., Zahedifard, F., Doroud, D., Doustdari, F., Vasei, M., Papadopoulou, B., & Rafati, S. (2013) · Parasite Immunology · doi:10.1111/pim.12042 · Cited by 55
Wang, J.-Y., Wang, Y., & Xia, M. (2016) · Nanoscale Research Letters · doi:10.1186/s11671-016-1698-9 · Cited by 50
Bansal, K. K., Gupta, J., Rosling, A., & Rosenholm, J. M. (2018) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2018.01.006 · Cited by 49
Self-citationGomes, F. L. T., Maranhão, R. C., Tavares, E. R., Carvalho, P. O., Higuchi, M. D. L., de Mattos, F. R., Pitta, F. G., Hatab, S. A., Filho, R. K., & Junior, C. V. S. (2018) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248418778836 · Cited by 42
Cytotoxicity Effect of Solid Lipid Nanoparticles on Human Breast Cancer Cell Lines
Abbasalipourkabir, R., Salehzadeh, A., & Abdullah, R. (2011) · Biotechnology(Faisalabad) · doi:10.3923/biotech.2011.528.533 · Cited by 40
Kaur, A., Goindi, S., & Katare, O. P. (2016) · Journal of Microencapsulation · doi:10.1080/02652048.2016.1216189 · Cited by 40
Solid Lipid Nanoparticles as Drug Delivery System
Kamble, V. A., Jagdale, D. M., & Kadam, V. J. (2010) · International Journal of Pharma and Bio Sciences · Cited by 38
Negi, L. M. S., Talegaonkar, S., Jaggi, M., Verma, A. K., Verma, R., Dobhal, S., & Kumar, V. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.09.061 · Cited by 37
Self-citationGene Delivery in the Cornea: In Vitro & Ex Vivo Evaluation of Solid Lipid Nanoparticle-Based Vectors
Vicente-Pascual, M., Albano, A., Solinís, M. Á., Serpe, L., Rodríguez‐Gascón, A., Foglietta, F., Muntoni, E., Torrecilla, J., del Pozo‐Rodríguez, A., & Battaglia, L. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0112 · Cited by 32
Squalene containing solid lipid nanoparticles, a promising adjuvant system for yeast vaccines
Stelzner, J. J., Behrens, M., Behrens, S., & Mäder, K. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.03.019 · Cited by 27
Bhushan, S., Kakkar, V., Pal, H. C., Mondhe, D. M., & Kaur, I. P. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.11.022 · Cited by 22
Nanotechnology in Ophthalmic Drug Delivery: A Survey of Recent Developments and Patenting Activity
Pignatello, R., & Puglisi, G. (2011) · Current Nanomedicine · doi:10.2174/1877912311101010042 · Cited by 21
Lakkadwala, S., Nguyen, S., Lawrence, J. G., Nauli, S. M., & Nesamony, J. (2014) · Journal of Microencapsulation · doi:10.3109/02652048.2014.898707 · Cited by 15
Khurana, L. K., Singh, R., Singh, H., & Sharma, M. (2018) · Current Pharmaceutical Design · doi:10.2174/1381612824666180403115106 · Cited by 14
REVIEW ON NANOPARTICLES USED IN COSMETICS AND DERMAL PRODUCTS
Patwekar, S. L., Gattani, S. G., Giri, R., Bade, A., Sangewar, B., & Raut, V. (2014) · Cited by 10
A MODERN REVIEW ON SOLID LIPID NANOPARTICLES AS NOVEL CONTROLLED DRUG DELIVERY SYSTEM
Reddy, A., Parthiban, S., Vikneswari, A., & Senthilkumar, G. P. (2014) · Cited by 10
Cited by
Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021) · ACS Nano · doi:10.1021/acsnano.1c04996 · Cited by 2,221
Therapeutic efficacy of nanoparticles and routes of administration
Chenthamara, D., Subramaniam, S., Ramakrishnan, S. G., Krishnaswamy, S., Essa, M. M., Lin, F.-H., & Qoronfleh, M. W. (2019) · Biomaterials Research · doi:10.1186/s40824-019-0166-x · Cited by 1,055
Lipid Nanoparticles as Carriers for Bioactive Delivery
Dhiman, N., Awasthi, R., Sharma, B., Kharkwal, H., & Kulkarni, G. T. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.580118 · Cited by 345
Zheng, B., & McClements, D. J. (2020) · Molecules · doi:10.3390/molecules25122791 · Cited by 344
Eleraky, N. E., Allam, A., Hassan, S. B., & Omar, M. M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020142 · Cited by 342
Metadata
- Authors
- Mishra, V., Bansal, K. K., Verma, A., Yadav, N., Thakur, S., Sudhakar, K., & Rosenholm, J. M.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2018-10-18
- Volume
- 10
- Issue
- 4
- Pages
- 191
- ISSN
- 1999-4923 (ISSN-L)
- OpenAlex
- W2896399282
- Cited by
- 669
- References
- 86
- FWCI
- 18.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.